|
GB0600168D0
|
|
A therapeutic composition
|
|
SG153877A1
|
|
Treatment of cancer
|
|
GB0503566D0
|
|
Treatment for cancer
|
|
GB0420845D0
|
|
Treatment of cancer
|
|
GB0414885D0
|
|
Cancer therapy
|
|
GB0414886D0
|
|
Treatment of bacterial infections
|
|
GB0409077D0
|
|
Treatment of fungal infections
|
|
GB0309126D0
|
|
Clostridium difficile focussed antibodies
|
|
GB0306782D0
|
|
Treatment of infection due to clostridium difficile
|
|
GB0130267D0
|
|
Focussed antibody technology
|
|
GB0127983D0
|
|
Treatment of micro-organism infection
|
|
GB0019049D0
|
|
Combinatorial chemistry method
|
|
GB0008305D0
|
|
Treatment of fungal infections
|
|
GB9923858D0
|
|
Antimicrobial compositions
|
|
GB9902555D0
|
|
Medicament
|
|
GB9806762D0
|
|
Treatment and diagnosis of staphylococcal infections
|
|
GB9715177D0
|
|
Medicament
|
